急诊快速性心房颤动治疗药物比较  

Treatment of rapid atrial fibrillation

作　　者：丁宗发 旷辅铭 伍松涛 

机构地区：[1]重庆市云阳县人民医院急诊科,重庆云阳404500

出　　处：《海南医学院学报》2011年第6期766-768,共3页Journal of Hainan Medical University

基　　金：海南医学院科研基金资助学报项目(0020110191)~~

摘　　要：目的:探讨急诊中控制快速型心房颤动心室率的安全有效药物。方法:选取我院2009年3月至2010年12月急诊科快速性心房颤动患者79例,按照治疗方法分为索托洛尔组、维拉帕米组和西地兰组。各组均静脉注射给药,目标心室率设定为100次/min,观察并对比各组的达标时间。结果:索托洛尔组总有效率为84.62%,维拉帕米组总有效率为65.38%,西地兰组总有效率为44.44%。三组治疗前、后心室率比较差异具有统计学意义(P<0.05)。结论:索托洛尔注射液治疗快速性心房颤动比维拉帕米和西地兰静脉推注临床效果好,具有时间短,安全性高的特点,值得在临床中推广应用。Objective： To investigate the safe and effective drugs to treat rapid atrial fibrillation.Methods： A total of 79 patients with rapid atrial fibrillation were divided into sotalol group,verapamil group and cedilanid group in Emergency Department of our hospital from March 2009 to December 2010,and all were administered intravenously.The target heart rate was set at 100 times/min.The duration was observation and compared among three groups.Results： The total efficacy of sotalol group was 84.62%,65.38% in verapamil group,and 44.44% in cedilanid group.And there was significant difference in ventricular rate among three groups（P0.05）.Conclusions： The treatment of sotalol is more effective than verapamil and cedilanid in treating rapid atrial fibrillation.It is of short time,high security,and is worthy clinical application.

关 键 词：急诊 快速性心房颤动 治疗观察 

分 类 号：R541.75[医药卫生—心血管疾病]